This week sees the publication of two large phase III randomized controlled trials of inhaled aztreonam in bronchiectasis. The global studies investigated whether patients with chronic Gram-negative …

 A record number of abstracts featuring bronchiectasis are presented the ERS 2014 meeting. Below is a list of some of the key sessions featuring bronchiectasis abstracts

Room B2-1 …

Congratulations to EMBARC's Felix Ringshausen for today winning the ERS best abstract award for his study

"Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis"

The …

The European Bronchiectasis Network (EMBARC) seeks to promote clinical research in bronchiectasis and to build research capacity in Europe. A key task in this will be identifying the areas of …

The EMBARC registry is now open for registration. Centres are able to sign up to participate in the EU wide registry of non-CF bronchiectasis. Instructions on how to register and to access the CRF …

International bronchiectasis researchers reported new data at the American Thoracic Society 2014 conference last week, with important new work in bronchiectasis reported. Highlights of two …

A randomized controlled trial from investigators in Australia suggests that 8 weeks of supervised exercise training can reduce the frequency of exacerbations in patients with bronchiectasis. Previous …

The European Respiratory Society has recognised EMBARC by awarding the European Bronchiectasis Network status as an official Clinical Research Collaboration (CRC). The three year partnership with the …

Over 100 investigators and centres in 21 countries have now joined the EMBARC network. The participation of so many enthusiastic researchers across Europe will ensure the success of the EMBARC …